Skip to main content
Premium Trial:

Request an Annual Quote

The BioCommerce Week Index: May 19, 2005

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(
May 17, 2005)
Last Price
(
May 10, 2005)
% Change
Agilent
A
22.48
21.86
2.84
Applied Biosystems
ABI
22.45
22.45
0.00
BD
BDX
58.96
59.17
-0.35
Beckman
BEC
68.1
66.38
2.59
Bio-Rad
BIO
51.92
52.58
-1.26
Bruker
BRKR
3.99
3.54
12.71
GE
GE
36.8
35.83
2.71
Harvard Bio
HBIO
2.9
3.4
-14.71
Invitrogen
IVGN
78.34
76.52
2.38
Molecular Devices
MDCC
18.29
18.81
-2.76
PerkinElmer
PKI
18.57
18.88
-1.64
Sigma
SIAL
59.37
59.54
-0.29
Stratagene
STGN
8.64
9.19
-5.98
Thermo
TMO
26.8
26.15
2.49
Waters
WAT
38.81
40.03
-3.05
Index Average
34.43
34.29
0.41

Bruker Shares Lead Winners Thanks to $1.1M in CEO's Insider Buys

Shares in Bruker climbed 12.71 percent during the five-day trading period ended Tuesday, making it the leading gainer for the BCW companies in a week in which the Index grew at an anemic .41 percent and losers outnumbered gainers.

Bruker's stock has been climbing since May 10 when CEO Frank Laukien launched a buying spree that cost him more than $1.1 million and earned him 277,430 shares.

According to Insidercow.com, which tracks insider trading at public companies, Laukien bought the stock at prices between $3.60 and $3.00 per share between May 10 and May 17.

Leading the losers last week was Harvard Bio, whose shares tanked 14.71 percent soon after the company released its annual 10-Q with the SEC. The company has lost more than one-third of its market cap since early March.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.